Titan Pharmaceuticals
TTNP
#10473
Rank
โ‚น0.57 B
Marketcap
โ‚น432.75
Share price
-3.76%
Change (1 day)
27.44%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น412.09. In 2023 the company made an earnings per share (EPS) of -โ‚น695.58 an increase over its 2022 EPS that were of -โ‚น1,426.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น695.58-51.22%
2022-โ‚น1,426-15.61%
2021-โ‚น1,690-81.37%
2020-โ‚น9,068-77.52%
2019-โ‚น40,346-56.32%
2018-โ‚น92,370-59.51%
2017-โ‚น2,28,154-371.81%
2016โ‚น83,938-144.35%
2015-โ‚น1,89,245300%
2014-โ‚น47,311-121.54%
2013โ‚น2,19,660-151.38%
2012-โ‚น4,27,492-11.54%
2011-โ‚น4,83,252188.89%
2010-โ‚น1,67,280-10%
2009-โ‚น1,85,866
2007-โ‚น7,62,052-2.38%
2006-โ‚น7,80,638-39.13%
2005-โ‚น12,82,477-16.87%
2004-โ‚น15,42,690-22.43%
2003-โ‚น19,88,7694.9%
2002-โ‚น18,95,83661.9%
2001-โ‚น11,70,957-13.7%
2000-โ‚น13,56,82465.01%
1999-โ‚น8,22,281-35.87%
1998-โ‚น12,82,259-1824.71%
1997โ‚น74,347-102.4%
1996-โ‚น31,03,966

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,046-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น675.87-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น133.30-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น81.67-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.47-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น365.16-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA